Android app Apple app link

PTC Therapeutics, Inc. (PTCT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$63.16
Day's range
$69.17

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/14/2026 Barclays Eliana Merle $122.00 $71.97   69.52%
05/08/2026 Morgan Stanley Judah Frommer $94.00 $75.36   24.74%
04/10/2026 Raymond James Tiago Fauth $108.00 $69.11   56.27%
02/23/2026 Barclays Eliana Merle $120.00 $70.66   69.83%
02/20/2026 RBC Capital Brian Abrahams $82.00 $67.95   20.69%
11/05/2025 Wells Fargo Tiago Fauth $93.00 $67.72   37.33%
11/05/2025 Barclays Gena Wang $68.00 $67.72   0.41%
10/28/2025 Jefferies Kelly Shi $77.00 $67.86   13.47%
08/08/2025 Robert W. Baird Joel Beatty $70.00 $45.38   54.25%
05/07/2025 Robert W. Baird Joel Beatty $66.00 $36.19   82.37%
01/07/2025 RBC Capital Brian Abrahams $58.00 $44.61   30.02%
11/27/2024 Robert W. Baird Joel Beatty $52.00 $45.09   15.34%
10/11/2024 Morgan Stanley Jeffrey Hung $45.00 $38.48   16.94%
08/26/2024 UBS Colin Bristow $47.00 $34.99   34.32%
07/12/2024 Morgan Stanley Jeffrey Hung $32.00 $33.20   -3.61%
05/20/2024 Goldman Sachs Paul Choi $32.00 $40.12   -20.24%
05/20/2024 Jefferies Kelly Shi $46.00 $39.81   15.55%
04/26/2024 Morgan Stanley Jeffrey Hung $30.00 $28.57   5.01%
08/30/2021 UBS Colin Bristow $45.00 $43.65   3.09%

PTC Therapeutics Inc FAQ's

PTC Therapeutics Inc has been rated by research analysts at Leerink Partners, Barclays, Wells Fargo, Morgan Stanley, Cantor Fitzgerald, RBC Capital in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.